FDA Inspection 971393 — Algunas Inc., dba Woodland Hills Compounding Pharmacy

Algunas Inc., dba Woodland Hills Compounding Pharmacy — FEI 3011830726

The FDA completed an inspection of Algunas Inc., dba Woodland Hills Compounding Pharmacy on April 29, 2016 in Woodland Hills, CA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
April 29, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Woodland Hills, CA (United States)

Citations

IDCFRDescription
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
202721 CFR 211.192Investigations of discrepancies, failures
241921 CFR 211.198(a)Complaint Handling Procedure